Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.

de Jong, Lisa A; Groeneveld, Jessie; Stevanovic, Jelena; Rila, Harrie; Tieleman, Robert G; Huisman, Menno V; Postma, Maarten J; van Hulst, Marinus · PLoS One · 2022

Where this comes from

Record sourced from PubMed, PMID 35358286.
Also identified by DOI 10.1371/journal.pone.0266625 and PMC identifier 8970364.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0222658.].

Read the full text

View on PubMed · Publisher (DOI)